Amit's Blog

From Socialist Cartels to Capitalist Wild Wests, and the Rise of the Indian Franchise Empire The staggering financial disparity between globally beloved European football and domestically focused American sports leagues reveals a profound economic paradox. While the English Premier League commands over three billion viewers, the National Football League generates nearly twenty billion dollars more in annual revenue, driven not by audience size but by structural engineering. American leagues operate as closed, risk-insulated cartels with artificial scarcity, salary caps, and heavy revenue sharing, effectively socializing billionaire wealth. European football, conversely, thrives on an open, hyper-competitive free market that prioritizes sporting merit over financial stability, leaving clubs vulnerable to relegation and wage inflation. India’s IPL has successfully fused these models, creating a sovereign financial grid that dominates global valuations through scarcity, auction mechanic...

Biology, Culture, and the Global Convergence Toward a 12–13% "Dutch Ceiling."   Why approximately 10% of the world's population has always been left-handed is one of evolutionary biology's most persistent puzzles.  The trait survives not despite being a minority but because of it. Through a mechanism called frequency-dependent selection, left-handers gain a "surprise advantage" in competitive interactions precisely because their movements are unfamiliar to the right-handed majority. This evolutionary benefit is balanced by biological costs and centuries of cultural suppression. However, as digital technologies and modern education erode the practical disadvantages of being left-handed, global reported rates are converging toward a natural equilibrium of 12–13%—a phenomenon known as the "Dutch ceiling." This article synthesizes the latest evolutionary, genetic, neuroscientific, and cross-cultural research to explain why left-handedness has nev...

From Process Patents to Compulsory Licensing – A Nation's Fight for Affordable Medicine   Between 1970 and 2026, India transformed from a colonial-era patent follower into the world's most aggressive defender of affordable medicine. Through a trilogy of legal innovations—process patents, Section 3(d)'s anti-evergreening provisions, and compulsory licensing—India built what experts call the "hard stop" at twenty years of patent protection, compared to thirty to forty years in the West. Yet this pharmaceutical sovereignty comes with a paradox: while India supplies sixty percent of the world's vaccines and forty percent of America's generic drugs, it remains ninety to one hundred percent dependent on China for the raw ingredients of basic antibiotics. This article examines the legal battles, the trade-offs, and the emerging counter-offensive as India navigates between public health and geopolitical vulnerability.   Part One: The Accidental Empire – Ho...